Alliancebernstein L.P. Igm Biosciences, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 41,230 shares of IGMS stock, worth $284,487. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,230

Previous 41,230 -0.0%

Holding current value

$284,487

Previous $283,000 140.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $58,134 - $102,427	8,930 Added 27.65%	41,230 $283,000
Q4 2023 Feb 14, 2024	SELL	$3.94 - $8.79 $12,056 - $26,897	-3,060 Reduced 8.65%	32,300 $268,000
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $17,249 - $27,557	2,590 Added 7.9%	35,360 $295,000
Q2 2023 Aug 15, 2023	BUY	$8.86 - $14.0 $60,868 - $96,180	6,870 Added 26.53%	32,770 $302,000
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $24,781 - $41,736	1,604 Added 6.6%	25,900 $440,000
Q3 2022 Nov 15, 2022	SELL	$15.42 - $27.01 $9,313 - $16,314	-604 Reduced 2.43%	24,296 $552,000
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $131,373 - $252,450	9,900 Added 66.0%	24,900 $449,000
Q3 2021 Nov 10, 2021	SELL	$65.76 - $90.65 $32,880 - $45,325	-500 Reduced 3.23%	15,000 $986,000
Q2 2021 Jul 30, 2021	BUY	$57.98 - $96.6 $202,930 - $338,100	3,500 Added 29.17%	15,500 $1.29 Million
Q1 2021 May 06, 2021	SELL	$71.56 - $121.23 $71,560 - $121,230	-1,000 Reduced 7.69%	12,000 $920,000
Q4 2020 Feb 08, 2021	SELL	$47.41 - $115.03 $4,741 - $11,503	-100 Reduced 0.76%	13,000 $1.15 Million
Q3 2020 Nov 12, 2020	BUY	$43.0 - $84.01 $90,300 - $176,421	2,100 Added 19.09%	13,100 $967,000
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $138,510 - $203,066	2,700 Added 32.53%	11,000 $803,000
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $261,533 - $612,125	8,300 New	8,300 $466,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $200M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Igm Biosciences, Inc. Transaction History